NasdaqCM - Delayed Quote • USD
CervoMed Inc. (CRVO)
At close: 4:00 PM EDT
After hours: 7:07 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.46 | -0.39 | -1.5 | -2.38 |
| Low Estimate | -0.49 | -0.48 | -1.87 | -3.15 |
| High Estimate | -0.44 | -0.31 | -1.13 | -1.62 |
| Year Ago EPS | -2.05 | -0.7 | -0.82 | -1.5 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 1M | 2M | 8.1M | 5.45M |
| Low Estimate | -- | 2M | 8M | 5M |
| High Estimate | 2M | 2M | 8.2M | 5.9M |
| Year Ago Sales | -- | 1.53M | 7.14M | 8.1M |
| Sales Growth (year/est) | -- | 31.10% | 13.40% | -32.70% |
Earnings History
| CURRENCY IN USD | 9/30/2022 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -3.09 | -0.95 | -0.29 | -0.39 |
| EPS Actual | -2.05 | -0.7 | -0.38 | -0.41 |
| Difference | 1.04 | 0.25 | -0.09 | -0.02 |
| Surprise % | 33.70% | 26.30% | -31.00% | -5.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.46 | -0.39 | -1.5 | -2.38 |
| 7 Days Ago | -0.46 | -0.39 | -1.5 | -2.38 |
| 30 Days Ago | -0.42 | -0.37 | -1.37 | -2.21 |
| 60 Days Ago | -0.21 | -0.61 | -1.43 | -2.53 |
| 90 Days Ago | -0.21 | -0.61 | -2.05 | -2.87 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CRVO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 77.60% | -- | -- | 7.90% |
| Next Qtr. | 44.30% | -- | -- | 10.20% |
| Current Year | -82.90% | -- | -- | 4.80% |
| Next Year | -58.70% | -- | -- | 12.50% |
| Next 5 Years (per annum) | -- | -- | -- | 11.27% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 4/8/2024 |
| Initiated | Canaccord Genuity: Buy | 2/15/2024 |
Related Tickers
SLNO Soleno Therapeutics, Inc.
40.78
-0.92%
IDYA IDEAYA Biosciences, Inc.
37.53
-0.48%
DNTH Dianthus Therapeutics, Inc.
21.92
-2.79%
TRAW Traws Pharma, Inc.
0.6044
-2.63%
LBPH Longboard Pharmaceuticals, Inc.
18.66
-0.74%
ACST Acasti Pharma Inc.
2.6300
-3.31%
MORF Morphic Holding, Inc.
30.78
-0.08%
QTTB Q32 Bio Inc.
26.22
+0.85%
LENZ LENZ Therapeutics, Inc.
15.39
-1.97%
REPL Replimune Group, Inc.
5.18
-0.77%